Faculty Summaries
Ranee Mehra, MD
Ranee Mehra, MD
Assistant Professor

Recent Publications

  • Andrews G, Lango M, Cohen R, Feigenberg S, Burtness B, Mehra R, Ahmed S, Nicolaou N, Gaughan J, Ridge JA. Non-surgical management of oropharyngeal, laryngeal and hypopharyngeal cancer: the Fox Chase Cancer Center experience. Head Neck, in press, 2010.
  • Rusthoven KE, Feigenberg SJ, Raben D, Kane M, Song JI, Nicolaou N, Mehra R, Burtness B, Ridge J, Swing R, Lango M, Cohen R, Jimeno A, Chen C. Initial results of a phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phys. 2010;78:1020-1025.
  • Turaka A, Li T, Sharma NK, Li L, Nicolaou N, Mehra R, Burtness B, Cohen RB, Lango MN, Horwitz EM, Ridge JA, Feigenberg SJ. Increased recurrences using intensity-modulated radiation therapy in the postoperative setting. Am J Clin Oncol. 2010 Dec;33(6):599-603.
  • Burtness B, Gibson M, Egleston B, Mehra R, Thomas L, Sipples R, Quintanilla M, Lacy J, Watkins S, Murren JR, Forastiere AA. Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer. Ann Oncol. 2009 Jul;20(7):1242-8.
  • Borghaei H, Mehra R, Simon G. Current issues in adjuvant chemotherapy for resected, stage IB non-small-cell lung cancer. Fut Oncol. 2009;5:19-22.
  • Mehra R, Treat J. Part II: Treatment of non-small-cell lung cancer: chemotherapy. In: Fishman's Pulmonary Diseases and Disorders (Fishman, A.P., Elias, J.A., eds.), 4th ed., pp. 1867-1882. McGraw-Hill, Medical Publishing Division, NY, 2008. Book Chapter
  • Mehra R, Cohen RB, Harari P. Targeted therapies in head and neck cancer. In: Combining Targeted Biological Agents With Radiotherapy: Current Status and Future Directions (Small, W., ed.), pp. 107-138. Demos Medical Publishers, NY, 2008. Book Chapter
  • Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clin Adv Hematol Oncol. 2008;6:742-750.
  • Mehra R, Cohen RB. New agents in the treatment for malignancies of the salivary and thyroid glands. Hematol Oncol Clin North Am. 2008;22:1279-1295.
  • Mehra R, Burtness B. Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trials. Expert Opin Biol. 2006;Ther. 6:951-962.